 Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. NASDAQ: AIKI recently released its 1st-quarter report, which revealed the strongest balance sheet in the companys history with approximately 102 million in cash and cash equivalents. 